We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$33.1B
AUM Growth
+$1.62B
Cap. Flow
+$885M
Cap. Flow %
2.67%
Top 10 Hldgs %
37%
Holding
1,568
New
69
Increased
691
Reduced
367
Closed
73

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$864M
2
BAC icon
Bank of America
BAC
+$84.7M
3
EW icon
Edwards Lifesciences
EW
+$69M
4
BABA icon
Alibaba
BABA
+$65.5M
5
AMD icon
Advanced Micro Devices
AMD
+$56.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$83.9M
2
TYL icon
Tyler Technologies
TYL
+$73.9M
3
CNM icon
Core & Main
CNM
+$73M
4
ITRI icon
Itron
ITRI
+$71.3M
5
UBER icon
Uber
UBER
+$70.5M

Sector Composition

Rank Sector Weight
1 Technology 36.91%
2 Healthcare 15.81%
3 Financials 12.06%
4 Communication Services 11.11%
5 Consumer Discretionary 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDL
1151
DELISTED
Avadel Pharmaceuticals
AVDL
$784K ﹤0.01%
36,400
+2,300
+7% +$44.7K
WSBC icon
1152
WesBanco
WSBC
$4.1B
$784K ﹤0.01%
23,600
ITGR icon
1153
Integer Holdings
ITGR
$4.25B
$779K ﹤0.01%
9,937
CATY icon
1154
Cathay General Bancorp
CATY
$4.31B
$778K ﹤0.01%
16,088
MBC icon
1155
MasterBrand
MBC
$1.89B
$773K ﹤0.01%
70,000
+35,900
+105% +$420K
TPH
1156
DELISTED
Tri Pointe Homes
TPH
$773K ﹤0.01%
24,555
BKU icon
1157
Bankunited
BKU
$3.41B
$772K ﹤0.01%
17,332
EWTX icon
1158
Edgewise Therapeutics
EWTX
$4.69B
$772K ﹤0.01%
31,100
-7,300
-19% -$147K
FCPT icon
1159
Four Corners Property Trust
FCPT
$2.76B
$772K ﹤0.01%
33,495
+1,200
+4% +$28.6K
THO icon
1160
Thor Industries
THO
$4.11B
$772K ﹤0.01%
7,523
RARE icon
1161
Ultragenyx Pharmaceutical
RARE
$2.6B
$771K ﹤0.01%
33,523
+6,400
+24% +$210K
BOKF icon
1162
BOK Financial
BOKF
$8.85B
$767K ﹤0.01%
6,472
KFY icon
1163
Korn Ferry
KFY
$4.36B
$766K ﹤0.01%
11,602
SHAK icon
1164
Shake Shack
SHAK
$2.98B
$763K ﹤0.01%
9,400
+500
+6% +$44.1K
TXG icon
1165
10x Genomics
TXG
$7.58B
$763K ﹤0.01%
46,800
+11,600
+33% +$175K
AKR icon
1166
Acadia Realty Trust
AKR
$2.86B
$761K ﹤0.01%
37,032
BHF icon
1167
Brighthouse Financial
BHF
$3.42B
$758K ﹤0.01%
11,700
NEOG icon
1168
Neogen
NEOG
$2.59B
$757K ﹤0.01%
108,364
-600
-0.6% -$3.77K
LEVI icon
1169
Levi Strauss
LEVI
$8.63B
$755K ﹤0.01%
36,400
-9,900
-21% -$213K
AUPH icon
1170
Aurinia Pharmaceuticals
AUPH
$2.02B
$753K ﹤0.01%
47,200
BL icon
1171
BlackLine
BL
$1.82B
$752K ﹤0.01%
13,600
-136,700
-91% -$7.53M
WAFD icon
1172
WaFd
WAFD
$2.81B
$752K ﹤0.01%
23,474
TPC
1173
Tutor Perini Cor
TPC
$4.98B
$751K ﹤0.01%
+11,200
New +$735K
GOLF icon
1174
Acushnet Holdings
GOLF
$5.25B
$750K ﹤0.01%
9,400
CLSK icon
1175
CleanSpark
CLSK
$2.96B
$749K ﹤0.01%
74,000

Similar funds

Handelsbanken Fonder's Q4 2025 Portfolio in Review

As of Q4 2025, Handelsbanken Fonder held 1,568 positions worth $33.1B, up 5.1% from $31.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Handelsbanken Fonder's Q4 2025 filing shows 69 new, 691 increased, 367 reduced and 73 closed positions. Its largest new stake was Fluence Energy: 857,654 shares worth $17M. The largest sale was Eli Lilly, an estimated $83.9M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Financials.

  • Handelsbanken Fonder's largest Q4 2025 buy was Fluence Energy: 857,654 shares worth $17M.
  • Handelsbanken Fonder added most to Amazon in Q4 2025, an estimated $864M increase.
  • Handelsbanken Fonder's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $83.9M.
  • Handelsbanken Fonder fully exited Kellanova in Q4 2025, selling an estimated $26M.
  • Handelsbanken Fonder's ten largest holdings make up 37% of its $33.1B portfolio in Q4 2025.
  • Handelsbanken Fonder opened 69 new positions and closed 73 in Q4 2025.
  • Handelsbanken Fonder's portfolio value rose 5.1% quarter-over-quarter to $33.1B.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.